Related Experiment Video
Updated: May 30, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
An overview of triple infection with hepatitis B, C and D viruses
Mehwish Riaz1, Muhamad Idrees, Hifza Kanwal
1National Centre of Excellence in Molecular Biology, University of the Punjab, 87-West Canal Bank Road Thokar Niaz Baig Lahore-53700, Pakistan.
Insights
Triple hepatitis infection, involving Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Hepatitis Delta Virus (HDV), poses a significant global health challenge. This review synthesizes data on the epidemiology, pathogenesis, and management of these co-infections.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Viral hepatitis, particularly Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV), is highly endemic in South East Asia, including Pakistan.
- Hepatitis Delta Virus (HDV) co-infection is also prevalent worldwide.
- HCV, HBV, and HDV share transmission routes, leading to frequent dual or triple infections, exacerbating liver damage, cirrhosis (LC), and hepatocellular carcinoma (HCC).
Purpose of the Study:
- To review the epidemiology, pathogenesis, transmission, symptoms, diagnosis, replication, disease outcomes, treatment, and prevention of triple hepatitis infections (HCV, HBV, HDV).
- To synthesize existing literature on triple hepatitis infections, focusing on risk factors and awareness.
Main Methods:
- A comprehensive literature review was conducted using PubMed, PakMediNet, DOAJ, and Google Scholar.
- Keywords included 'epidemiology of triple infection,' 'risk factors,' 'awareness status,' 'treatment,' and 'replication cycle.'
- Data from 74 studies published between 1983 and 2010 were analyzed.
Main Results:
- Triple hepatitis infections involving HCV, HBV, and HDV are a significant concern due to overlapping transmission and synergistic effects on liver disease progression.
- Chronic HDV infection contributes to liver damage and has oncogenic potential, similar to HBV and HCV.
- The review synthesizes available data on the multifaceted aspects of these triple infections.
Conclusions:
- Triple hepatitis infections represent a complex clinical challenge with serious implications for liver health, including increased risk of cirrhosis and cancer.
- Understanding the epidemiology, pathogenesis, and transmission is crucial for effective prevention and treatment strategies.
- Further research and public health initiatives are needed to combat the burden of these co-infections.
Abstract:
Viral hepatitis is one of the major health problems worldwide, particularly in South East Asian countries including Pakistan where hepatitis C virus (HCV) and hepatitis B virus (HBV) infections are highly endemic. Hepatitis delta virus (HDV) is also not uncommon world-wide. HCV, HBV, and HDV share parallel routes of transmission due to which dual or triple viral infection can occur in a proportion of patients at the same time. HBV and HCV are important factors in the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). In addition to LC and HCC, chronic HDV infection also plays an important role in liver damage with oncogenic potential.The current article reviews the available literature about the epidemiology, pathogenesis, transmission, symptoms, diagnosis, replication, disease outcome, treatment and preventive measures of triple hepatitis infection by using key words; epidemiology of triple infection, risk factors, awareness status, treatment and replication cycle in PubMed, PakMediNet, Directory of Open Access Journals (DOAJ) and Google Scholar. Total data from 74 different studies published from 1983 to 2010 on triple hepatitis infections were reviewed and included in this study. The present article briefly describes triple infection with HCV, HBV and HDV.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Viruses with RNA Genomes
Viral Recombination
Retrovirus Life Cycles

